All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
More information on our cookie policy.
BioWorld. Link to homepage.
Powering insights from Cortellis. Link to Cortellis page on Clarivate website.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Artificial intelligence
Coronavirus
Diagnosing the state of COVID-19 testing
Drugs to Watch 2020
The next pandemic
Premium reports
BioWorld Financings Reports
Disease Forecast Reports
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, November 25, 2020
See today's BioWorld
Home
» Tau Gains Popularity as Alzheimer's Drug Target
Looking to read the full article? Subscribe to BioWorld.
Tau Gains Popularity as Alzheimer's Drug Target
July 2, 2012
By
Brian Orelli
No Comments
Just as multiple drugs targeting amyloid-beta are set to read out Phase III results, a new Alzheimer's disease target, tau, is gaining popularity.
BioWorld
Already a subscriber?
Sign in